Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Marchiafava-Bignami disease in chronic alcoholic patient.
Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.
[A treatment of neuromyelitis optica (Devic's disease) during pregnancy].
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis.
Acute Motor-dominant Polyneuropathy as Guillain-Barré Syndrome and Multiple Mononeuropathies in a Patient with Sjögren's Syndrome.
Vitamin D and Alzheimer's Disease: Neurocognition to Therapeutics.
AxonSeg: Open Source Software for Axon and Myelin Segmentation and Morphometric Analysis.
The contribution of neutrophils to CNS autoimmunity.
No evidence of disease activity in multiple sclerosis patients.
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion.
Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis.
Nodo-paranodopathy, internodopathy and cleftopathy: Target-based reclassification of Guillain-Barré-like immune-mediated polyradiculoneuropathies in dogs and cats.
Multiple Approaches to Multiple Sclerosis (and Other Demyelinating Diseases).
Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
Structural sex differences at disease onset in multiple sclerosis patients.
Revisiting the role of erythropoietin for treatment of ocular disorders.
Safety of secukinumab in the treatment of psoriasis.
Best Practices for Intrathecal Baclofen Therapy: Patient Selection.
Commentary on: Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
Orthopaedic manifestations and diagnostic clues in children with Guillain-Barré syndrome.
Nanoparticles restore lysosomal acidification defects: Implication for Parkinson and other lysosomal-related diseases.
The development of an observational screening tool to assess safe, effective and appropriate walking aid use in people with multiple sclerosis.
The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis.
Intrathecal Dexmedetomidine for Anaesthetic Management of a Patient with Chronic Inflammatory Demyelinating Polyneuropathy.
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface.
Pages
« first
‹ previous
…
735
736
737
738
739
740
741
742
743
…
next ›
last »